Company Search:
Advanced Search
Sponsored Links
Guard Therapeutics International AB (publ) Company Snapshot
Guard Therapeutics International AB (publ) operates within the Commercial nonphysical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guard Therapeutics International AB (publ) with three other miscellaneous service companies in Europe: Read-Gene SA of POLAND (2013 sales of 268,384.25 Polish New Zlotys [US$71,360.69 ] ), General Technologies AG of GERMANY (82,294.51 Euros [US$97,505.00 ] of which 100% was Investment Income), and European Institute of Science AB (735,712.00 Swedish Kronor [US$83,834.38 ] of which 100% was Bio Medical Research).

Sales Analysis.
  Stock Performance Chart for Guard Therapeutics International AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 1.53
(Figures in Swedish Kronor)
1 Week 8.2%   13 Weeks 8.6%  
4 Weeks 22.5%   52 Weeks -1.7%  
Guard Therapeutics International AB (publ) Key Data:
  Ticker: GUARD Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Nonphysical Research
  2013 Sales 715,000
(Year Ending Jan 2014).
Employees: 5
  Currency: Swedish Kronor Market Cap: 240,978,427
  Fiscal Yr Ends: December Shares Outstanding: 157,708,395
  Share Type: Aktie Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.